Differential phosphorylation of c-Cbl in leukemogenic and nonleukemogenic HTLV-I cell lines

International Journal of Virology

Volumn 2, Issue 1, 2006, Pages 39-49

  Samaan, Angela ^a   Haddad, Elias ^b   Mahana, Wahib ^a,c  

^a Groupe d'Immunologie Microbienne   (France)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c NONE   (France)

Author keywords

c Cbl; HTLV I; Oncogene; Phosphoprotein; T cell activation; Ubiquitin ligases

Indexed keywords

CBL PROTEIN; PERVANADATE; PHOSPHOPROTEIN; PROTEIN SH2; PROTEIN SH3; UBIQUITIN PROTEIN LIGASE; VAV PROTEIN; VIRUS DNA;

ANIMAL CELL; ARTICLE; CELL LINE; CELL LYSATE; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOPRECIPITATION; IN VITRO STUDY; LEUKEMOGENESIS; LYMPHOID CELL LINE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTO ONCOGENE; RABBIT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIRUS CARCINOGENESIS; WESTERN BLOTTING;

HUMAN T-LYMPHOTROPIC VIRUS 1; ORYCTOLAGUS CUNICULUS;

EID: 33748200659     PISSN: 18164900     EISSN: None     Source Type: Journal    
DOI: 10.3923/ijv.2006.39.49     Document Type: Article

References (42)

1. Andoniou, C.A., B.F.C. Thien and W.Y. Longdon, 1994. Tumor induction by activated abl involves tyrosine phosohorylation of the product of the Cbl oncogene. EMBO J., 13: 4515-4523.
2. Andoniou, C.E., N.L. Lill, C.B. Then, M.L. Jr. Lupher, S. Ota, D.D. Bowtell, R.M. Scaife, W.Y. Langdon and H. Band, 2000. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation. Mol. Cell. Biol., 20: 851-867.
3. Arron, J.R., M. Vologodskaia, B.R. Wong, M. Naramura, N. Kim, H. Gu and Y. Choi, 2001. A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation. J. Biol. Chem., 10: 30011-30017.
4. Barabe, F., C. Gilbert, N. Liao, S.G. Bourgoin and P.H. Naccache, 1998. Crystal-induced neutrophil activation VI. Involvment of Fc gamma, R IIIB (CD16) and CD11b in response to inflammatory microcrystals. FASEB. J., 12: 209-220.
5. Blake, T.J., M. Shapiro, H.C. Morse and W.Y. Langdon, 1991. The sequences of the human and mouse c-Cbl proto-oncogenes show v-Cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif Oncogene, 6: 653.
6. Bustelo, X.R., P. Crespo, M. Lopez-Barahona, J.S. Gutkind and M. Barbacid, 1997. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation. Oncogene, 15: 2511-2520.
7. Chin, H., T. Saito and A. Arai et al., 1997. Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2 and Cbl in hematopoietic cells. Biochem. Biophys. Res. Commun., 239: 412.
8. Daniel, M.D., L.V. Melendez and R.D. Hunt et al., 1974. Herpsvirus-saimiri. VII. induction of malignant lymphoma in New Zealand white rabbit. J. Natl. Cancer. Inst., 53: 1803-1807.
9. Donovan, J.A, R.L. Wange, W.Y. Langdon and L.E. Samelson, 1994. The protein product of the c-Cbl protooncogene is the 120 kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J. Biol. Chem., 16: 22921-22924.
10. Feshchenko, E.A., S.K. Shore and A.Y. Tsygankov, 1999. Tyrosine phosphorylation of c-Cbl facilitates adhesion and spreading while suppressing anchorage-independent growth of V-Abl-transformed NIH3T3 fibroblasts. Oncogene, 18: 3703-3715.
11. Jain, S.K., W.Y. Langdon and L. Varticovski, 1997. Tyrosine phosphorylation of p120Cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase. Oncogene, 14: 2217.
12. Joazeiro, C.A., S.S. Wing, H. Huang J.D. Leverson, T. Hunter and Y.C. Liu, 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Sciences, 8: 309-312.
13. Jongeward, G.D., T.R., Clandinin and P.W. Sternberg, 1995. Sli-1, a negative regulator of let-23-mediated signaling in C. elegans. Genetics, 139: 1553-1566.
14. Kaabeche, K., J. Lemonnier, S. Le Mee, J. Caverzasio and P.J. Marie, 2004. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. J. Biol. Chem., 279: 36259-36267.
15. Kamei, T., K. Machida, Y. Nimura, T. Senga, I. Yamada, S. Yoshii, S. Matsuda and M. Hamaguchi, 2000. c-Cbl protein in human cancer tissues is frequently tyrosine phosphorylated in a tumor-specific manner. Intl. J. Oncol., 17: 335-339.
16. Kim, M., T. Tezuka, K. Tanaka and T. Yamamoto, 2004. Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation. Oncogene, 4: 1645-1655.
17. Langdon, W.Y., 1995. The Cbl oncogene: A novel substrate of protein tyrosine kinases. Aust. N Z J. Med., 25: 859-864.
18. Liu, Y.C., A. Altman, 1998. Cbl: complex Formation and functional implications. Cell Signal, 10: 377-385.
19. Mahana, W., T.M. Zhao, R. Teller, M.A. Robinson and T.J. Kindt, 1998. Genes in the PX region of human T cell leukemia virus I influence Vav Phosphorylation in T cells. Proc. Natl. Acad. Sci. USA. 95: 1782-1787.
20. Marengere, L.E., C. Mirtsos, I. Kozieradzki, A. Veillette, T.W. Mak and J.M. Penninger, 1999. Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells. J. Immunol., 159: 70-76.
21. Migone,T.S., J.X. Lin and A. Ceresto et al., 1995. Constitutively activated Jak-STAT pathway in T cell transformed with HTLV-1. Sci., 269: 79-81.
22. Miyake, S., M.L. Lupher Jr, B. Druker and H. Band, 1998. The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha. Proc. Natl. Acad. Sci., USA., 7: 7927-7932.
23. Ota, Y. and L.E. Samelson, 1997. The product of the proto-oncogene c-Cbl: A negative regulator of the Syk tyrosine kinase. Sci., 276: 418-420.
24. Panchamoorthy, G., T. Fukazawa and S. Miyake et al., 1996. p120 Cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors and the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem., 271: 3187.
25. Poiesz, B.J., F.W. Ruscetti, A.F. Gazdar, P.A. Bunn, J.D. Mina and R.C. Gallo, 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lyphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA. 77: 7415-7419.
26. Rao, N., S. Miyake, A.L. Reddi, P. Douillard, A.K. Ghosh, I.L. Dodge, P. Zhou, N.D. Fernandes and H. Band, 2002. Negative regulation of Lck by Cbl ubiquitin ligase. Proc. Natl. Acad. Sci. USA., 19: 3794-3799.
27. Rao, N., I. Dodge and H. Band., 2002. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system. J. Leukoc Biol., 71: 753-763.
28. Sawasdikosol, S., B.H. Hague and T.M. Zhao et al., 1993. Selection of rabbit CD4, CD8 TCR γδ+ cells by in vitro transformation with human T lymphotropic virus type I. J. Exp. Med., 178: 1337-1345.
29. Scholz, G., K. Cartledge and A.R. Dunn, 2000. Hck enhances the adherence of lipopolysaccharide-stimulated macrophages via Cbl and phosphatidylinositol 3-kinase. J. Biol. Chem. 12: 14615-14623.
30. Secrist, J.P., L.A. Burns, L. Karnitz, G.A. Koretzky and R.T. Abraham. 1993. Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol. Chem., 15: 5886-5893.
31. Seto, A., M., Kawanishi, S. Matsuda, K. Ogawa, T. Eguchi and I. Miyoshi, 1987. Induction of preleukemic stage of adult T cell leukemia-like disease in rabbits. Jpn. J. Cancer. Res., 78: 1150.
32. Shackelford, J. and J. S. Pagano, 2004. Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination. Mol. Cell Biol., 24: 5089-5093.
33. Simpson, M.R., M. Leno, B.S. Hubbard and T.J. Kindt, 1996. Cutaneous manifestation of human T cell leukemia virus type 1 infection in experimental model. J. Infec. Dis., 173: 722-726.
34. Takemoto, S., J.C. Mulloy and A. Cereseto et al., 1997. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of Jak/STAT proteins. Proc. Natl. Acad. Sci. USA., 94: 13897-13902.
35. Tanaka, S., L. Neff, R. Baron and J.B. Levy, 1995. Tyrosine phosphorylation and translocation of the c-Cbl protein after activation of tyrosine kinase signaling pathways. J. Biol. Chem., 270: 14347-14351.
36. Tanaka, S., M. Amling and L. Neff et al., 1996. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature, 383: 528.
37. Teckchandani, A.M., E.A. Feshchenko and A.Y. Tsygankov, 2001. c-Cbl facilitates fibronectin matrix production by v-Abl-transformed NIH3T3 cells via activation of small GTPases. Oncogene, 20: 1739-1755.
38. Wunderlich, L., A. Goher, A. Farago, J. Downward and L. Buday, 1999. Requirement of multiple SH3 domains of Nck for ligand binding, Cell Signalling, 11: 253-262.
39. Xu, X., O. Heidenreich and I. Kitajima et al., 1996. Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Oncogene, 13: 135-142.
40. Yamanashi, Y., S. Mori and M. Yoshida et al., 1989. Selective expression of a protein-tyrosine kinase, p56 lyn in hematopoitic cells and association with production of human T-cell lymphotropic virus type I. Proc. Natl. Acad. Sci. USA., 86: 6538-6542.
41. Zhao, T.M., M.A. Robinson, S. Sawasdikosol, R.M. Simpson and T.J., Kindt, 1993. Variation in HTLV-1 sequences from rabbit cell lines with diverse in vivo effects. Virology, 195: 271-274.
42. Zhao, T.M., M.A. Robinson, F.S. Bowers and T.J. Kindt, 1995. Characterization of an infectious molecular clone of human T-cell leukemia virus type 1. J. Virol., 69: 2024-2030.